Amprius Technologies, Inc. (NYSE:AMPX) Q1 2023 Earnings Call Transcript

Amprius Technologies, Inc. (NYSE:AMPX) Q1 2023 Earnings Call Transcript May 14, 2023

Operator: Good afternoon. Welcome to Amprius Technologies’ First Quarter 2023 Earnings Conference call. Joining us for today’s presentation are the Company’s CEO, Dr. Kang Sun, and CFO, Sandra Wallach. At this time, all participants are in listen-only mode. Following management’s remarks, we will open the call for questions. Please note that this presentation contains forward-looking statements, including, but not limited to statements regarding future product commercialization, new customer adoption, and timing and ability of Amprius to build its large-scale manufacturing facility, expand it manufacturing capacity, scale its business, and achieve a sustainable cost structure. These statements involve known and unknown risks, uncertainties, and other important factors that may cause Amprius’ results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied in such forward-looking statements.

For a more complete discussion of these risks and uncertainties, please refer to Amprius’ filings with the Securities and Exchange Commission including, but not limited to the discussion of Amprius risk factors in it’s quarterly report on Form 10-Q filed on March 30, 2023. Finally, I would like to remind everyone that this conference call is being webcast and a recording will be made available for replay on the Company’s Investor Relations website at ir.amprius.com. In addition to the webcast, the Company has posted a shareholder letter that accompanies these results, which can also be found on the Investor Relations website. I will now turn the call over to Amprius Technologies’ CEO, Dr. Kang Sun, for his comments. Sir, please proceed.

Kang Sun: Welcome, everyone, and thank you for joining us this afternoon. After I report on our progress and accomplishments at Amprius in the first quarter, our CFO, Sandra Wallach, will discuss our financial results for the period. After that, I will share some closing remarks before opening the call for questions. As some of you may know, Amprius is a ultra-high energy density lithium-ion battery developer and manufacturer. Our high performance batteries are based on Amprius’ proprietary high capacity silicon anode technologies. Today, Amprius delivers commercial batteries with 450 watt-hour per kilo specific energy density and the 1,150 watt-hour per liter volumetric energy density. Our batteries also have up to 10C power capability and enables extreme fast charging rates of 0% to 80% state of charging in approximately six minutes.

Amprius batteries are viewed for the tough operating environments with the durability to pass the United States military benchmark nail penetration test as well as the versatility to operate in an extremely wide temperature range of minus 30 degrees Celsius to up to 55 Celsius. Is our belief that there is no one else in the commercial market that can perform at these levels. Amprius has over 80 patents and extensive know-how in silicon anode manufacturing technologies. Amprius has been in commercial battery production since 2018, so the company has many years of manufacturing experience of high energy density, high power density lithium-ion batteries. Our near-term goal is to scale our manufacturing with the long-term goal of becoming a mainstream battery solution with applications across all segments of electrical mobility, including aviation and EV industries.

Building our momentum from last year, we believe that we have hit the ground running so far in 2023, with new technological breakthroughs, continued commercial successes, and additional developments for our production capacity expansion. Our first quarter achievements were important steps towards accomplishing our goal for 2023. I would now like to highlight a few events. In March, we announced the Amprius new battery platform, which is independently verified for 500 watt-hour per kilo specific energy density and a 1,350 watt-hour per liter volumetric energy density. Our 500 watt-hour per kilo battery platform was purposely designed to serve the needs of certain strategical customer projects, such as AALTO HAPS, the Airbus subsidiary developing high-altitude pseudo satellites.

We expect to be able to ship prototypes to these select customers before the end of 2023. Amprius’ 500 watt-hour per kilo and the 1,350 watt-hour per liter battery platform not only enhances our customer applications, it also demonstrates the robust product roadmap for Amprius silicon anode technologies. The company will continue to move along that roadmap to deliver the most advanced lithium-ion batteries available on the market. This achievements follows our most recent announcement in December of 2022 that an independent third-party had verified our passing of the Military Performance Specification Nail Penetration Test with unprecedented 390 watt-hour per kilo cell. Amprius’ innovative polymer electrolyte prevents the penetrating nail from creating a more resilient shorter circuit as indicated by the minimal increase in cell temperature after penetration and only small increase in cell voltage.

After nail penetration, the cell is still functioning and providing power, a critical capability for variable batteries used by soldiers. Also we announced earlier this month and after a vigorous selection process, Amprius high energy density batteries were selected by the University of Michigan solar car team for their upcoming 3,000 kilometer race at World Solar Challenge in Australia. The batteries for the race must provide exceptional performance in tough conditions. Our leading performance characteristics are undeniable and this should provide the team with an edge for the event. We look forward to working with their team in the coming months. Moving to our business development efforts. We continue to see significant demand for our products in the first quarter, especially in the aviation and the EV markets.

As cruising distance and the weight are critical property for aviation, our high energy density lightweight batteries provide the ideal solutions, allowing us to develop safety roads in the industry. This quarter was highlighted by the successes both across our existing customer, as well as the new customer opportunities. We shipped to 19 customers in the first quarter, including several new accounts. Among a serious of ongoing new business development opportunities, we kicked off a new technical engagement this quarter, with the leading aerospace OEM, codifying next steps towards testing and evaluation of Amprius batteries. Also, within our existing clients, we spend our relationship with AeroVironment to be the supplier of a key power element in AeroVironment Switchblade 300 Block 20 missile.

We expect to continue our regularly scheduled commercial shipments to AeroVironment as well as to Teledyne Flir, two repeat customers and the strong partners for Amprius. In addition, we have received a significant interest from other existing battery pack manufacturing partners for sizable, expanded contracts to serve the larger aviation segment, including in hundreds of megawatts through 2025 and beyond. Our pipeline of interested partners continues to grow, and we believe that our efforts to build out our manufacturing capacity will lead to additional new and expanded orders in the coming quarters. As we think about our goals for the next several years, our primary focus remains on expanding capacity to meet demand and ultimately achieve a sustainable cost structure at scale.

After a transformational 2022, with several strategic moves including two cost-sharing grants that we were selected to receive from the United States Department of Energy, we continued to make important strides towards our goals in our first quarter. First, we recently expanded our facility at Amprius Lab in Fremont, California to accommodate our first large-scale anode production machine from centrotherm. We now process the second half of our existing facility, which we expect allows us to both affect our high-volume manufacturing processes and increase our capacity for silicon anode battery production to approximately two megawatt hour or 10x our current production capacity exiting 2033. We look forward to better serving strategic aviation customers’ needs and supporting prototyping and qualification projects with new customers who are currently in our backlog.

We also announced in March that we had a selective site in Brighton, Colorado as the location for our approximately 775,000 square foot large-scale production facility, the first mass production site for next generation battery technology in the United States. The selection of the Colorado for our gigawatt-scale factory marks an important milestone for Amprius. The initial phase of our buildout will provide a potential of up to 5 gigawatt, with expansion capability for up to a total potential manufacturing capacity of a 10 gigawatt. As a reminder, Amprius Fab is already equipped with the electrical power and existing structural layout needed for gigawatt scale lithium-ion battery factory, which will reduce build-out costs and time to market with the goal of being operational in 2025.

Also, Brighton is closer to some of our materials distributors in the Northwestern United States, which we expect will lower operational costs over the long time factory. As part of our 18 to 24 months plan to scale, we signed our lease for Amprius Fab in April. We are aiming to begin retrofitting the facility towards the end of summer. Overall, this new facility will transform our long-term production capabilities. In the near-term, we will continue to develop and achieve cutting-edge products from Amprius’ lab in Fremont, while we refine our manufacturing processes to further derisk the handoff of our mass production to Amprius Fab in Brighton, Colorado in the coming years. I have one final update before I turn the call over to Sandra. Labeling our entire operation here at Amprius is our exceptional team and the ongoing support from our Board of Directors.

We recently announced that we have extended our Board and appointed Kathleen Bayless as an Independent Director and our Auditing Committee Chair. With her extensive management and the Board experience, we look forward to her unique perspectives on our Board moving forward. We are excited to have her on our team as we work to execute our growth strategy. With the overview complete, I will now turn the call over to our CFO, Sandra Wallach, to review our financial results for the quarter. Sandra?

Sandra Wallach: Thank you, Kang. I would now like to spend a few minutes covering some key updates. As a reminder our detailed financials can be found in our shareholder letter. We closed out the first quarter with 0.7 million in revenue, compared to 2.1 million in Q1 2022. This decrease was partially due to a decrease of 1.5 million in development services revenue, and a decrease of 0.1 million for the quarter year-over-year in product revenue, both partially offset by an increase of 0.2 million and government grant revenue. Of note, due to the timing of customer shipments, we ended the quarter with both 0.5 million more in product inventory than in the same quarter last year and 2.5 million in increased deferred revenue pending final delivery of performance obligations later this year.

As we’ve noted in previous quarters, our product revenue is driven by customer purchase orders arriving at uneven times throughout the year and development services revenue is intermittent based on revenue recognition timing. However, as Kang mentioned earlier, we shipped to nearly 20 customers this quarter, including four new customers, and we believe that our business development efforts continue to gain traction. Once our capacity expands and more customers transition to commercial orders, we expect to see a more even ramp of product revenue. Our GAAP gross margin was negative 504% in the first quarter, primarily due to non-recurring startup charges for our large-scale manufacturing facility. These charges included both a 1.4 million broker charge for our economic incentives negotiation and 0.3 million of pre-construction design firm startup costs.

As the build out continues, we expect that more one-time charges are likely to arise. Still, we forecast that our GAAP gross margin will begin to normalize as we reach our capacity expansion goals in the coming years. Moving now to our operating expense management. Our GAAP operating expenses for the first quarter increased to 6.3 million, largely due to increased public company cost and additional investment in R&D staffing. Our GAAP net loss for the first quarter was 9.1 million or a net loss of $0.11 per share. Our shares outstanding at March 31, 2023 were 85 million. As of March 31, 2023, there were 65 full time employees, primarily based in our Fremont, California location, and our share based compensation was 0.7 million for the first quarter.

Now turning to the balance sheet. We exited the first quarter with 64.2 million in cash and no debt. The key drivers of our cash activity for the quarter were 6.5 million used in operating activities. As we previously discussed, our run rate for cash used in operating activities is projected to be around 2 million per month in addition to 2022 audit cost and transaction related expenses. Other drivers include 1.1 million of investment into the expansion of our Amprius Lab facility in Fremont and 2.1 million in financing cash inflow related to usage of our committed equity facility. These activities resulted in a total net use of cash of 5.5 million for the quarter. Considering our business achievements and ongoing projects, we believe we have been efficiently using capital to drive Amprius forward.

Moving to our outlook, we still expect to be limited by manufacturing capacity until we exit 2023 when our new 2 megawatt capacity is projected to come online. Regarding revenue, we have several ongoing development services programs with performance obligations that we expect to complete within 2023, which means that we should see increased revenue recognition weighted more heavily towards the latter part of the year. We anticipate that our G&A costs will continue at the higher rate we experienced exiting 2022 when accounting for additional public company expenses. Also, we plan to continue to be lean on other operating expenses as we strategically add critical mass to our Amprius Lab and Amprius Fab operating units and allocate the majority of our capital to scaling up our manufacturing.

To this end, we expect higher capital expenditures going forward as we continue to fully build out the 2 megawatt capacity at Amprius Lab and design and construct our gigawatt hour scale and Amprius Fab facility. Our spending pattern is dependent on several factors outside of our control, including the timing of rezoning approval for the Colorado site, so we expect to provide more specific projections as we have additional information to share. As we work to fund the capital requirements for our scale up in excess of our previously noted cost sharing grants from the U.S. Department of Energy, we expect that we will continue to have strong support from the U.S. Inflation Reduction Act as we access production tax credits at the anode and cell level.

In addition, we have received over $10 million in state and local incentive packages related to our gigawatt scale facility, which is the result of significant partnerships built in Colorado through our selection process. We believe that these tailwinds will further enhance our economics as we accelerate our scale to meet our massive market. Overall with the strength of the balance sheet and multiple vehicles to generate additional funding through both equity, such as warrants and are committed equity facility, and non-dilutive sources, such as grants, loans, and incentives, we believe we will have enough cash to execute on our strategic plan. One last item. Based on the recommendation of a special Independent Board Committee, we entered into a merger agreement with Amprius, Inc, our 77% stockholder.

Under the merger agreement, among other things, the shares of common stock currently owned by Amprius Inc. will be canceled and we will issue to the stockholders of Amprius, Inc. new shares of our common stock based on the negotiated and dismounted exchange ratio, and we will assume all options and warrants outstanding at Amprius, Inc. The newly issued shares will be subject to the same lockup that applies to Amprius, Inc.’s current shares. The merger is conditioned on, among other things, the approval of a majority of the stockholders of Amprius Technologies that are not affiliated with either Amprius, Inc, or held by any of our directors or officers. We expect the special meeting to approve the merger will occur in the third quarter of this year.

For more information, please reference the Form 8-K we filed earlier today. With that, I will conclude the financial discussion and pass the call back to Kang.

Kang Sun: Thanks, Sandra. I’d like to reemphasize a few points before closing. First, we are delivering next generation commercially available lithium-ion batteries today. Our market-leading technology and the position in the aviation space are reflective of our unmatched performance in real world applications and our batteries’ ability to solve real world problems. As shown by our recent increase in battery specific energy density from 450 to 500 watt-hour per kilo, we will continue to enhance our product performance and set new industry standards. Second, we have been initiating commercial products since 2018. So our focus today is not on commercializing, instead, we are building out the scale to serve a significant demand in the U.S. to support U.S. based supply chain resilience.

Exiting 2023, we will further pull out our large-scale manufacturing process and the parameters with our two megawatt hour production line at the Amprius Lab in Fremont. We are also moving swiftly to prepare the build-out of Amprius Fab, our gigawatt scale facility in Brighton, Colorado, but the first 500 megawatt hour demonstration program with the United States Department of Energy. In the meantime, we are using our limited capacity to provide the necessary samples to potential customers moving through the technical to commercial validation process. Third, we are looking forward to several exciting milestones over the rest of the 2023. In the second half of the year, we expect to finalize the optimal transition process for our mass production to develop silicon anode, begin construction of Amprius Fab, deliver prototypes of our 500 watt-hour per kilo battery to select customers, and operationalize our two megawatt production line at Amprius Lab by end of the year.

As we look to the rest of the year, our strategy and the focus at Amprius remains unchanged. We have a tremendous opportunity ahead. We support our portfolio that position us to both growth in the aviation market and extend to other industries, taking batteries with a stronger performance and a faster charging time. We are continuing to build our early lead with technological advancement and strategical partnerships. Both the private and the public sector, we now have the capital and are building the capacity to become the leading commercial provider in a sustainable mobility sector. Finally, we believe we have the right team in place to execute our mission and deliver what we have planned and the promise over the last decade. Thank you for your continued support of Amprius Technologies.

With that, I will turn it back to the operator for the Q&A.

Q&A Session

Operator: Thank you. The floor is now open for questions. [Operator Instructions] And our first question comes from Colin Rusch from Oppenheimer. Go ahead, Colin.

Operator: And our next question comes from Chris Souther from B. Riley. Go ahead, Chris.

Operator: Thank you. And our next question comes from Chip Moore from EF Hutton. Go ahead, Chip.

Operator: At this time, this concludes our question-and-answer session. If your question was not taken, you may contact Amprius’ Investor Relations team at ir@amprius.com. I would now like to turn the call back over to Dr. Sun for his closing remarks.

Kang Sun: Thanks again, everyone, for joining us today. I’d also like to thank our employees, partners, and shareholders for their continued support. As a reminder, you may learn more about our company from the additional updates and learn about upcoming events and the presentations from the Investor Relations section of our website. We look forward to updating you on Amprius’ progress on our next call. Thanks.

Operator: Thank you for joining us today for Amprius Technologies first quarter 2023 earnings conference call. You may now disconnect your lines and have a wonderful day.